Arthritis News and Research

Latest Arthritis News and Research

Mylan announces U.S. launch of Celecoxib Capsules

Mylan Inc. today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's Celebrex Capsules, which is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults.

10 Dec 2014

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported that it will initiate a pre-clinical development program of its next generation drug CF602 for the indication of sexual dysfunction. Upon successful completion, the company intends to file an IND with the FDA to allow human Phase I studies.

9 Dec 2014

Arthritis drug baricitinib meets primary endpoint in Phase 3 RA-BEACON study

Eli Lilly and Company and Incyte Corporation today announce that the Phase 3 RA-BEACON study of the investigational medicine baricitinib met its primary endpoint of improved ACR20 response compared to placebo after 12 weeks of treatment.

9 Dec 2014

Zydus Cadila becomes world's first company to launch biosimilar of Adalimumab

After more than a decade-long wait, the revolutionary therapy that provided a new lease of life to millions of patients suffering from rheumatoid arthritis and other auto immune disorders globally will now be accessible to patients in India. Zydus Cadila becomes the first company anywhere in the world to launch the biosimilar of Adalimumab - the world's largest selling therapy.

9 Dec 2014

Study: Key protein may help prevent tumor growth, promote wound healing

A key protein may represent a new way to use the immune system to speed healing and counter inflammatory, infectious and autoimmune diseases, according to study led by researchers at the Icahn School of Medicine at Mount Sinai and published in the December issue of Cell Reports.

7 Dec 2014

MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL

MorphoSys AG and Xencor Inc. today announced the publication of final results of a Phase 1/2a trial evaluating MOR208 (formerly XmAb5574) in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL).

7 Dec 2014

BRI signs license agreement with SOBI for Kineret (anakinra)

Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.

6 Dec 2014

York researcher examines male attitudes towards self-managing long-term health conditions

A researcher at the University of York, studying male attitudes towards self-managing long-term healthcare issues, has discovered that self-management support is better received by men if it does not threaten aspects of masculine identity.

5 Dec 2014

TSRI scientists identify 'mechanoreceptor' protein that mediates sense of touch in mammals

A team led by biologists at The Scripps Research Institute has solved a long-standing mystery in neuroscience by identifying the "mechanoreceptor" protein that mediates the sense of touch in mammals.

5 Dec 2014

Resveratrol in red wine inhibits formation of inflammatory factors that activate cardiovascular diseases

A natural substance present in red wine, resveratrol, inhibits the formation of inflammatory factors that trigger cardiovascular diseases. This has been established by a research team at the Department of Pharmacology of the University Medical Center of Johannes Gutenberg University of Mainz working in collaboration with researchers of the Friedrich Schiller University in Jena and the University of Vienna.

4 Dec 2014

Massage therapy: A natural way to strengthen the immune system this flu season

As seasons change our bodies become more susceptible to cold and flu. Massage therapy is a natural way to strengthen the immune system at this vulnerable time, especially if it is already weakened by stress, fatigue or poor nutrition.

4 Dec 2014

Meniscal surgery may increase risk of osteoarthritis, cartilage loss

A popular surgery to repair meniscal tears may increase the risk of osteoarthritis and cartilage loss in some patients, according to research presented today at the annual meeting of the Radiological Society of North America. The findings show that the decision for surgery requires careful consideration in order to avoid accelerated disease onset, researchers said.

3 Dec 2014

Australian Prescriber publishes top 10 subsidised drugs in Australia

The annual publication of the top 10 subsidised drugs appears in the December edition of Australian Prescriber. Statins (cholesterol-lowering medicines) top the lists again.

1 Dec 2014

Phenotyping human diseases in mice: an interview with Professor Carola Vinuesa

One of the main obstacles to finding effective therapies for human diseases has been our limited understanding of disease pathogenesis: we lack detailed knowledge of the cellular and molecular mechanisms that lead to the development of disease.

30 Nov 2014

Researchers use mathematical models to predict how immune cells respond to disease

Walter and Eliza Hall Institute researchers have defined for the first time how the size of the immune response is controlled, using mathematical models to predict how powerfully immune cells respond to infection and disease.

28 Nov 2014

Researchers say that nervous system may play vital role in infections, autoimmune diseases

The nervous system may play a bigger role in infections and autoimmune diseases than previously known. If researchers can learn more about that role, it could provide insight into diagnosing and treating everything from the stomach flu to rheumatoid arthritis.

27 Nov 2014

Arthritis News and Research

Latest Arthritis News and Research

Mylan announces U.S. launch of Celecoxib Capsules

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Arthritis drug baricitinib meets primary endpoint in Phase 3 RA-BEACON study

Zydus Cadila becomes world's first company to launch biosimilar of Adalimumab

Study: Key protein may help prevent tumor growth, promote wound healing

MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL

BRI signs license agreement with SOBI for Kineret (anakinra)

York researcher examines male attitudes towards self-managing long-term health conditions

TSRI scientists identify 'mechanoreceptor' protein that mediates sense of touch in mammals

Resveratrol in red wine inhibits formation of inflammatory factors that activate cardiovascular diseases

Massage therapy: A natural way to strengthen the immune system this flu season

Meniscal surgery may increase risk of osteoarthritis, cartilage loss

Australian Prescriber publishes top 10 subsidised drugs in Australia

Phenotyping human diseases in mice: an interview with Professor Carola Vinuesa

Researchers use mathematical models to predict how immune cells respond to disease

Researchers say that nervous system may play vital role in infections, autoimmune diseases

New approach to fighting breast, thyroid cancers

Two medical research bodies announce new research centre to tackle musculoskeletal disorders

Endocrine Society issues Clinical Practice Guideline on rare bone condition

Early support and education program has positive impact on people with rheumatoid arthritis

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Arthritis News and Research

Latest Arthritis News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in